Volume 194, number 12: Anderson et al. (2006; 194:1577-9)
14th Nov 2006, 01:00 GMT
Volume 194, number 12: Anderson et al. (2006; 194:1577-9) related news:
- Volume 194, number 12: Reply to Gargiullo et al. — J Infect Dis Latest Issue
- Volume 194, number 12: Reply to Achour et al. — J Infect Dis Latest Issue
- Volume 194, number 12: Increase in Serogroup C Meningococcal Disease in Canada Is Associated with Antigenic Changes in the Protein Antigens of the ET-15 Clone of Neisseria meningitidis — J Infect Dis Latest Issue
- Volume 194, number 12: Sandhu et al. (2006; 194:1428-37) — J Infect Dis Latest Issue
- International Patient Recruitment Presentation by Dr. Diana L. Anderson of D. Anderson & Company — PR Leap - Recent News Releases
- Volume 194, number 12: Reply to Tsang et al. — J Infect Dis Latest Issue
- Pamela Anderson vient de subir une fausse couche — Actustar.com - L'actualité people, les news et les potins des stars et des célébrités
- Volume 194, number 12: Is Human Herpesvirus-6 DNA in Plasma the Right Marker for Active Infection? — J Infect Dis Latest Issue
- Klatsch & Tratsch: Pamela Anderson wettert gegen«Super-Idioten» — SZOn - Lifestyle
- Keep emotions out of choosing stocks to get good returnsKnow when to cut losses and when to hang tough — NewsOk.com - Business
Latest news from J Infect Dis Latest Issue:
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector
- Volume 194, number 12: Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 DNA Candidate Vaccine
- Volume 194, number 12: Quantification of Viral Inactivation by Photochemical Treatment with Amotosalen and UV A Light, Using a Novel Polymerase Chain Reaction Inhibition Method with Preamplification
- Volume 194, number 12: Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV-1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138
- Volume 194, number 12: Evaluation of Purified Taenia solium Glycoproteins and Recombinant Antigens in the Serologic Detection of Human and Swine Cysticercosis
- Volume 194, number 12: Phase 1 Clinical Trials of the National Institutes of Health Vaccine Research Center HIV/AIDS Candidate Vaccines
- Volume 194, number 12: Is There a Safe Age for Vaccinating Infants with Tetravalent Rhesus-Human Reassortant Rotavirus Vaccine?
- Volume 194, number 12: Reply to Gargiullo et al.
- Volume 194, number 12: Is Panton-Valentine Leukocidin the Major Virulence Determinant in Community-Associated Methicillin-Resistant Staphylococcus aureus Disease?
- Volume 194, number 12: Human Cytolytic T Cell Recognition of Yersinia pestis Virulence Proteins That Target Innate Immune Responses